Introduction
In the early days of endocrinology hormones were recognized, and assayed, by some characteristic biological function. For example, corticotrophin (ACTH) was assayed by the amount of corticosterone which was produced in vivo as a response to the injection of graded amounts of this hormone into rats (Lipscomb & Nelson, 1962) . This was a simple and direct effect of ACTH. Equally, it could be assayed by the depletion in vivo of ascorbate from the adrenal gland (Sayers, Sayers & Woodbury, 1948) . Although there was a clear correlation between the loss of ascorbate from the adrenal and the concentration of ACTH acting on the gland, there was little information relating ascorbate depletion and secretion of corticosterone or cortisol (depending on the animal used in the assay). The obvious physiological effect of ACTH was to produce corticosterone (or cortisol), but the hormone could be assayed with reasonable precision by a secondary, or biochemical, phenomenon which is now recognized as being part of the biochemical mechanisms involved in steroidogenesis (Chayen, Daly, Loveridge & Bitensky, 1976) .
As regards the gonadotrophic hormones, the situation has been at least as complex. For example, a standard method of detecting and assaying LH has been to measure its ability to deplete ascorbate from the ovary, or more particularly, from the ovary of animals induced to superovulate (Parlow, 1961) . Equally, FSH has been assayed by the increased ovarian weight it induces (Steelman & Pohley, 1953) . Both these effects are less immediate than is the secretion of corticosterone in response to ACTH, yet both form the bases of reliable bioassays.
The application of physico-chemical analytic methods to the purification of polypeptide hor¬ mones made it possible to isolate the hormone. At the same time, the development of radiochemical and immunochemical techniques (e.g. Ekins, 1960; Yalow & Berson, 1960) opened the way to radioimmunoassay in which the molecular species itself, or specific antigenic determinants, were identified and measured (e.g. Yalow & Berson, 1960 , for insulin; Berson & Yalow, 1968 ; Landon & Greenwood, 1968) . These methods did not have to depend on a biological function, whether it was a primary or secondary function; they were able to determine the presence, and concentration, of specific molecules corresponding to that which gave the hormone its biological function. These methods were considerably more sensitive than were the older bioassays and can be considered to be 'analytical' techniques, akin to those of analytical chemistry.
Clearly certain precautions had to be, and were, taken. For example, there was no point in raising an antibody to the a-subunit of FSH since that antibody would cross-react with all glyco¬ protein hormones which have the common subunit. Equally, it was inadvisable to use an antibody to the C-terminal amino acids of ACTH when the biological activity resided in the N-terminal part; the former could give erroneous values for biological activity (as discussed by Besser et al, 1971) .
But in spite of all the precautions, some inadequacies of radioimmunoassay techniques had become evident, even as early as 1967 (see WHO Report, 1975 (WHO Report, 1975) , was that immunoassays measure a composite of antigenic activity which is not necessarily related to the bioactivity of the hormone. The recent evidence that most polypeptide hormones may occur in various, almost polymeric, forms (e.g. 'big' ACTH; 'big big' gastrin, as discussed by Yalow, 1974) , has meant that the mere recognition of a group of antigenic determinants is not synonymous with the identification of the biologically active hormone. Consequently interest has revived in the develop¬ ment of bioassays which depend on the functional capacity of the hormone to produce either its primary physiological function, or at least a biochemical function associated with it. Such bioassays would need to be performed in parallel with the analytical assays (radioimmunoassays) and have at least the same sensitivity as the latter (WHO Report, 1975 ).
As experience with radioimmunoassays has grown, so it has become apparent that, for some polypeptide hormones at least, even the sensitivity of these assays is inadequate. For example, the limit of sensitivity of the best radioimmunoassay for thyrotrophin (TSH) is about 1 µ /ml, yet it now seems clear that a considerable proportion of the normal human population has circulating levels of less than this amount. It is therefore difficult at present to decide whether low circulating levels of TSH are associated with certain clinical conditions. Moreover, it is unlikely that the present radio¬ immunoassays for parathyroid hormone (PTH) can measure even high levels of the biologically active hormone (Parsons & Potts, 1972 Histochemistry and cytochemistry were developed to make it possible to assign biochemical activity to specific cell types within a complex tissue. In general it may be said that histochemistry tended to be concerned predominantly with problems of localization, the exception being the work of Glick (e.g. 1961 Glick (e.g. , 1963 ; see also review by Symington, 1969) . In contrast, cytochemistry has been developed as quantitative cellular biochemistry. The point of similarity is that in histochemistry and cytochemistry the coloured reaction product is precipitated in the cell which produces the reaction. This is in contrast to the techniques normally used in biochemistry in which the reaction product is soluble and is measured in solution. Although this is convenient in that the reaction product can be measured very simply by spectrophotometry, it means that it is impossible to assess the activity of each cell type independently of the others. Yet if the target cells comprise 5 % of the mass of a tissue which shows 100 units of biochemical activity, then even a doubling of activity in the target cells (induced by the hormone) will produce only a 5 % increase overall. To overcome this 'tissue dilution artefact' (Chayen, Jones, Bitensky & Cunningham, 1961 ; Jones, Bitensky, Chayen & Cunningham, 1961) , quantitative cytochemistry uses (i) unfixed tissue sections which are free from measurable ice-artefact (Chayen & Bitensky, 1968; Altman & Barrnett, 1975) and which are sufficiently thin (10-20 µ ) for the histology to be ascertained; (ii) reaction media which contain optimal concentra¬ tions of reactants, just as in conventional biochemistry; (iii) reactions which produce a precipitated coloured reaction product in the cell which produced this product; and (iv) microdensitometry for measuring the amount of precipitated coloured reaction product in each responding cell, with the same degree of accuracy as that of conventional spectrophotometry (Bitensky, Butcher & Chayen, 1973) .
The techniques of cytochemistry, and their validation, have been discussed by Chayen & Bitensky (1968), Chayen et al. (1973a Chayen et al. ( ,b, 1974 and Bitensky et al (1973) . It has been shown that when these techniques are applied to tissues consisting of a predominantly single-cell type, their results, in absolute terms (e.g. µ H2/unit time), agree closely with those obtained by conventional bio¬ chemical procedures (e.g. Butcher, 1970; Altman, 1972; Chayen, 1977) .
The application of cytochemistry to the assay of hormones Considerable advances in our knowledge of the action of hormones have come from the studies of several workers, notably Gaillard (e.g. Gaillard & Schaberg, 1965) and Fell (e.g. Fell & Rinaldini, 1965 ; also see Laznitzki, 1965 ) who maintained tissues in organ culture and observed the effects of the relevant hormones on rates of growth, or other structural features. The cytochemical bioassays represent an extension of these studies in that they use the newer methods of quantitative cyto¬ chemistry to measure the biochemical changes induced by the hormone.
The general procedure for the simpler cytochemical bioassays, the cytochemical segment bio¬ assays, is as follows. fig. 2 ). Lastly, by taking 6 segments from one animal, the assay becomes a 'within-animal' assay (4 segments for the standard calibration graph and 2 for testing the plasma at two different concentrations), thus obviating the 'between-animal' variation which has been a source of imprecision in most bioassays.
Treatment with hormone
At the end of 5 h the medium is removed from each segment. For 4 segments it is replaced with fresh medium containing one of a graded series of concentrations of a standard hormone preparation. This provides the standard calibration graph (e.g. Text-fig. 3 ). The medium of the other 2 segments is replaced with fresh medium containing one of two concentrations of the plasma to be assayed. Because of the sensitivity of these assays, the plasma is usually diluted 1/100 and 1/1000. We therefore have a within-animal assay with two concentrations of the plasma which allows us to test whether the active principle in the plasma produces a response which is parallel to that of the standard prepara¬ tion. Having two concentrations of the same plasma also acts as a check on the precision of that particular assay; the results, calculated back to the original concentration, should agree to ± 15 % if reliance is to be placed on the assay. Petersen et al, 1975) .
Cytochemistry
At the time of maximal response to the hormone, the segments are chilled rapidly to -70°C. Later they are sectioned at, for example, 10 µ in a cryostat, with a cabinet temperature of -25°C and with the knife cooled to below -70°C by solid C02. The sections are flash dried off the knife on to a slide taken from the ambient temperature of the laboratory. These are standard methods for quanti¬ tative cytochemistry . To achieve constant thickness of sections, it is advisable to use an automatic cutting device, such as is fitted to the Bright FS/CS/LT/M cryostat, because the thickness varies with the speed of cutting (Butcher, 1971) . The sections are then tested for the par¬ ticular biochemical change induced by that particular hormone (see Table 1 by Bitensky et al, 1973; Chayen, 1977) .
The use of a suitable microdensitometer also increases the sensitivity inherent in the cytochemical bioassays. Firstly, it avoids the tissue dilution artefact discussed previously. Secondly, because of its construction, it can measure the extinction of a chromophore in a single cell, whereas conventional biochemistry requires about 106 cells. Thus on this count alone, it improves sensitivity by a factor of 106.
The cytochemical section bioassays The cytochemical segment assays require not less than 6 segments of the target tissue to make each assay a 'within-animal' assay and so avoid the considerable 'between-animal' variation that has detracted from reproducibility and sensitivity of in-vivo bioassays. It is, however, difficult to obtain more than 6 segments of thyroid or adrenal cortical tissue from any one guinea-pig. Consequently the assay of a single plasma sample, at two dilutions, requires one animal, and six measurements (see Text-fig. 3 ). The next plasma sample will also require a new calibration graph for the tissue of the second animal, in the tissue of which the sample is to be assayed. This is too laborious and too costly a process for routine assaying of many samples. Consequently, modifications in which the cells in sections of the target tissue are made to respond to the hormone have been developed for the cyto¬ chemical bioassay of ACTH (Alaghband-Zadeh, AlaghbandZadeh, 1974) and gastrin (Hoile & Loveridge, 1976) .
In the former, the adrenal tissue is maintained in vitro for 5 h, as in the segment assay. It is then stimulated by a low concentration (0-5 fg/ml) of the hormone, the effect of which is unmeasurable by these assays, but which appears to improve the sensitivity of the subsequent response. The tissue is then chilled, sectioned at 20 µ (greater than the largest dimension of the cells of the zona reticularis) and the sections, mounted back-to-back in duplicate, are exposed to the action of the hormone. The medium used for this exposure contains a colloid stabilizer to protect the unfixed sections which would otherwise disintegrate in a buffer solution at pH 7-6 (see Altman & Chayen, 1965 Validity of the cytochemical bioassays
For brevity the forms of validation used for the assay of ACTH will be taken as a model for all the cytochemical bioassays. Reproducibility. Variation between segments treated separately with the same concentration of hormone was < ± 4%; the coefficient of variation for results from 5 sections cut from 5 segments treated with different concentrations of the hormone was < 5 % for each concentration tested. The same two plasma samples tested on consecutive days gave results of (a) 14-7 and 14-7, and (b) 236 and 250 pg/ml (Chayen, Loveridge & Daly, 1972) .
Sensitivity. The lowest concentration of the hormone which consistently gives readings different from zero concentration, is 5 fg/ml (5 IO-15 g/ml). In human plasma, after suppression with cortisol, Rees et al (1973a) recorded 34 fg/ml; Holdaway, Rees, Ratcliffe, Besser & Kramer (1974) reported residual values of as low as 10 fg/ml in human plasma treated with an antibody to ACTH.
Precision. For a series of 10 assays, Buckingham (1974) reported that the index of precision was 0076 ± 0-002; the fiducial limits were 86-115 % to 98-101 % (Daly, Loveridge, Bitensky & Chayen, 1974) . The recovery of added hormone was 101-102% .
Specificity. Various other hormones, such as LH (which causes ascorbate depletion in the ovary but not in the adrenal), prolactin, the biologically inactive C-terminal ACTH peptide a18-39 showed virtually no cross-reaction; ßMSH, which shares some of the N-terminal amino acids, gave < 0-01 % cross-reaction (Holdaway et al, 1974) . The addition of a specific antibody to plasma containing ACTH produced 90% loss of the assayable activity (Holdaway et al, 1974 (Rees et al, 1973a) . In more dynamic situations, in which the hormone levels rise rapidly and fall quickly, as in the insulin hypoglycaemia test in vivo, differences between radioimmunoassay and the cytochemical bioassay became apparent during the period when the levels were falling (Fleisher, Glass, Bitensky, Chayen & Daly, 1974) . This would reflect the longer half-life of the hormone, as measured by the radioimmunoassay which was still detecting biologically inactive fragments (Besser et al, 1971) .
Advantages of the sensitivity of these assays For some hormones, the increased sensitivity of the assays allows the low, but normal, circulating levels in man to be determined for the first time, e.g. TSH (Petersen, Smith & Hall, 1975) . The recent studies of Chambers, Zanelli, Parsons & Chayen (1976) on parathyroid hormone could lead to determinations of the normal circulating levels of the biologically active form of this hormone.
In general, however, the increased sensitivity afforded by the cytochemical bioassays is useful in two situations: (a) when there are very low levels of the hormone, as in hypopituitarism (Holdaway, Rees & Landon, 1973) or (b) when very little blood can be taken safely. Holdaway et al (1973) used this form of assay to determine the level of ACTH in samples obtained by a heel-prick from neonates. Only small samples can be taken when studying the episodic secretion of hormones (Gallagher et al, 1973) , many samples being required over a period of some hours. About 1 ml blood is ample for samples which are to be measured at 1/100 and and 1/1000 dilution. Similar considerations pertain to sequential sampling from small laboratory animals. The apparatus used for the section assay of ACTH. In the background is the vessel used for treating the sections, which are back-to-back. In the foreground is the trough containing the cytochemical reagents for testing for ascorbate. At the end of 1 min the lid holding the sections is transferred to the cytochemical reaction trough.
